OVERCOMING ENZALUTAMIDE-RESISTANT WITH A NOVEL ANTI-AR PEPTIDE IN PROSTATE CANCER CELLS

被引：0
|
作者：
Zainfeld, Daniel
Chen, Ruibao
Thrasher, J. Brantley
Li, Benyi
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.2238
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP84-14
引用
收藏
页码：E1095 / E1095
页数：1
相关论文
共 50 条
  • [21] Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer
    Gokbayrak, Bengul
    Altintas, Umut Berkay
    Lingadahalli, Shreyas
    Morova, Tunc
    Huang, Chia-Chi Flora
    Fazlioglu, Betul Ersoy
    Yu, Ivan Pak Lok
    Kalkan, Batuhan M.
    Cejas, Paloma
    Kung, Sonia H. Y.
    Fazli, Ladan
    Kawamura, Akane
    Long, Henry W.
    Acilan, Ceyda
    Onder, Tamer T.
    Bagci-Onder, Tugba
    Lynch, James T.
    Lack, Nathan A.
    COMMUNICATIONS BIOLOGY, 2025, 8 (01)
  • [22] Neuropilin-2 promotes enzalutamide-resistant neuroendocrine prostate cancer
    Wang, Jing
    Li, Jingjing
    Wu, Boyang
    Yin, Lijuan
    CANCER RESEARCH, 2020, 80 (16)
  • [23] Aryl hydrocarbon receptor is critical for enzalutamide-resistant prostate cancer growth
    Chen, Chia-Hui
    Wu, Boyang Jason
    CANCER RESEARCH, 2024, 84 (06)
  • [24] A distinct epigenetic state sensitizes enzalutamide-resistant prostate cancer cells to BET bromodomain inhibition
    Shah, N.
    Arora, V. K.
    Karthaus, W.
    Wongvipat, J.
    Zheng, D.
    Sawyers, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S9 - S9
  • [25] Knockdown of EPS8 expression attenuates the proliferation of enzalutamide-resistant prostate cancer cells
    Huang, Wei-Lun
    Chen, Sih-Han
    Wu, Richard Chen-Yu
    Mai, Hsing-Cha
    Wu, Chun-Hsien
    Hsieh, Pei-Fang
    Pang, See-Tong
    Lin, Victor Chia-Hsiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (10):
  • [26] Prostate cancer RIPTAC™ therapeutics demonstrate activity in preclinical models of Enzalutamide-resistant prostate cancer
    Yu, Xinheng
    Eastman, Kyle J.
    Raina, Kanak
    Jones, Kelli M.
    Forbes, Chris D.
    Hundt, Abigail
    Garcia, Marco
    Stronk, Rebecca
    Howard, Katia
    McGovern, Andrew
    Chenard, Rebekka
    Denny, Allison
    Forgione, Mia
    Bassoli, Kyle
    Garvin, Ethan
    Mousseau, James J.
    Li, Hao
    King, Madeline P.
    Bhardwaj, Amit
    Kayser-Bricker, Katherine J.
    Crews, Craig M.
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Discovery of novel biphenyl derivatives as androgen receptor degraders for the treatment of enzalutamide-resistant prostate cancer
    Zhang, Wenqiang
    Fan, Yawen
    Zhang, Yan
    Feng, Yunrui
    Luo, Yi
    Zhou, Xiaoyu
    Chen, Zhuolin
    Wang, Chenxiao
    Lu, Tao
    Tang, Feng
    Chen, Yadong
    Li, Hongmei
    Jiao, Yu
    BIOORGANIC CHEMISTRY, 2024, 148
  • [28] Integrative transcriptional analysis of enzalutamide-resistant castration resistant prostate cancer cells using RNA sequencing.
    Kim, Tae Heon
    Kang, Minyong
    Oh, Ji Youn
    Kang, Yumi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [29] MCT INHIBITION AS A POTENTIAL THERAPEUTIC STRATEGY TO TARGET ENZALUTAMIDE-RESISTANT PROSTATE CANCER
    Bhattacharjee, Sayani
    Doan, Jonathan P.
    Pletcher, Jerred P.
    Wynn, Rebecca
    Petros, Firas
    Sindhwani, Puneet
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2020, 203 : E767 - E767
  • [30] Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants
    Banuelos, Carmen A.
    Ito, Yusuke
    Obst, Jon K.
    Mawji, Nasrin R.
    Wang, Jun
    Hirayama, Yukiyoshi
    Leung, Jacky K.
    Tam, Teresa
    Tien, Amy H.
    Andersen, Raymond J.
    Sadar, Marianne D.
    CANCERS, 2020, 12 (07) : 1 - 17
12345